← Therapeutics
Details checkedClinical trial listing onlyCheckedregistry
Donepezil Chronic Tinnitus Study
Also known as: Donepezil group, Donepezil for tinnitus
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule
Stage
Phase 4
Status
Active
Target Gene
—
Route / Mode
Oral
Confidence
78%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
Brazil
Population
adult, tinnitus, study-level
Trial IDs
1
Mechanism
Academic randomized double-blind trial of oral donepezil versus placebo for chronic sensorineural tinnitus symptoms.
Indications
Notes
ClinicalTrials.gov lists this University of Sao Paulo study as active, not recruiting, with an estimated 2025 completion date. It is a repurposed generic-drug academic trial, not a company-sponsored tinnitus product program.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT07153991
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-verified-studygeneric-drug-studynot-commercial-pipeline-program
Related Programs
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
AC102 by AudioCure Pharma
Company: AudioCure Pharma · Small Molecule · Phase 2
SPI-1005 by Sound Pharmaceuticals
Company: Sound Pharmaceuticals · Small Molecule · Phase 3
ACOU085 by Acousia Therapeutics
Company: Acousia Therapeutics GmbH · Small Molecule · Phase 2
CIL001 (Paliroden) by Cilcare
Company: Cilcare SAS · Small Molecule · Phase 1/2